Science Explorer Back to mapMap
Discussion

Asana Biosciences (United States)

Research works
26
▼ 75% vs 2018-21
Citations
410
15.6 per fractional work
Top-10% rate
13.4%
all institutions 10.0%
Open access
42%
world 40%
International
33%
world 18%

Not ranked overall: Asana Biosciences (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Asana Biosciences (United States) work in?

In all years, 44% of research at Asana Biosciences (United States) is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (44%), Biochemistry, Genetics and Molecular Biology (30%), Chemistry (8%). It does 2.0× the world's share of Life Sciences.

Health Sciences: 12 fractional works · 44.3% of its workMedicine: 12 fractional works · 44.3% of its workOncology: 3 fractional works · 11.1% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 10.4% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.8% of its workPathology and Forensic Medicine: 1 fractional works · 3.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.7% of its workDermatology: 1 fractional works · 2.6% of its workRheumatology: 1 fractional works · 2.4% of its workInfectious Diseases: 0 fractional works · 1.4% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 1.0% of its workHematology: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workInternal Medicine: 0 fractional works · 0.3% of its workUrology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workLife Sciences: 11 fractional works · 40.5% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 30.1% of its workMolecular Biology: 5 fractional works · 18.9% of its workGenetics: 1 fractional works · 5.5% of its workCancer Research: 1 fractional works · 5.0% of its workCell Biology: 0 fractional works · 0.4% of its workBiotechnology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 4.9% of its workImmunology: 1 fractional works · 4.4% of its workMicrobiology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 3.4% of its workPlant Science: 0 fractional works · 1.9% of its workFood Science: 0 fractional works · 0.9% of its workInsect Science: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.1% of its workPharmacology: 0 fractional works · 1.8% of its workPharmaceutical Science: 0 fractional works · 0.3% of its workPhysical Sciences: 4 fractional works · 14.9% of its workChemistry: 2 fractional works · 7.7% of its workOrganic Chemistry: 2 fractional works · 6.0% of its workSpectroscopy: 0 fractional works · 1.7% of its workComputer Science: 1 fractional works · 4.8% of its workComputational Theory and Mathematics: 1 fractional works · 4.8% of its workEngineering: 0 fractional works · 1.0% of its workBiomedical Engineering: 0 fractional works · 0.6% of its workCivil and Structural Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.9% of its workGlobal and Planetary Change: 0 fractional works · 0.3% of its workPollution: 0 fractional works · 0.3% of its workEcology: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workMathematics: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.0% of its workALL ITS WORKAsana Biosciences(United States)26fractional works, all years
Life Sciences41%Physical Sciences15%Health Sciences44%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine1244.3%
    1. Biochemistry, Genetics and Molecular Biology830.1%
    2. Immunology and Microbiology14.9%
    3. Agricultural and Biological Sciences13.4%
    4. Pharmacology, Toxicology and Pharmaceutics12.1%
    1. Chemistry27.7%
    2. Computer Science14.8%
    3. Engineering01.0%
    4. Environmental Science00.9%
    5. Materials Science00.4%
    6. Mathematics00.2%
    1. Social Sciences00.3%
    2. Economics, Econometrics and Finance00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.37× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.01× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.54× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 23.05× its world share, 0 worksPharmacology, Toxico…Chemistry: 7.57× its world share, 0 worksChemistryEngineering: 0.25× its world share, 0 worksEngineeringEnvironmental Science: 0.81× its world share, 0 worksEnvironmental ScienceMedicine: 1.96× its world share, 1 worksMedicineEconomics, Econometrics and Finance: 0.14× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.18× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 23.1×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics23.05×0 works
  2. Chemistry7.57×0 works
  3. Biochemistry, Genetics and Molecular Biology5.01×1 works
  4. Immunology and Microbiology3.54×0 works
  5. Medicine1.96×1 works
  6. Environmental Science0.81×0 works
  7. Agricultural and Biological Sciences0.37×0 works
  8. Engineering0.25×0 works
  9. Social Sciences0.18×0 works
  10. Economics, Econometrics and Finance0.14×0 works

Who are the top researchers at Asana Biosciences (United States)?

Ranked on the quality score, Niranjan Sathyanarayana Rao, Gupta Sandeep and Sanjeeva P. Reddy lead among researchers whose main affiliation is Asana Biosciences (United States).

  1. 1 Niranjan Sathyanarayana Rao United States · #943,408 worldwide 1.1k citations · 37 works
  2. 2 Gupta Sandeep United States · #2,790,882 worldwide 228 citations · 16 works
  3. 3 Sanjeeva P. Reddy United States · #2,951,705 worldwide 442 citations · 47 works
All ranked researchers at Asana Biosciences (United States)

What are the most cited papers from Asana Biosciences (United States)?

The most cited paper from Asana Biosciences (United States) is "T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma" (Jennifer N. Brudno et al., 2018), with 800 citations. Next come "Quantitative comparison of DNA methylation assays for biomarker development and clinical applications" (354) and "Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer" (269).

Most cited papers
#PaperReleasedCitations
1 T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma Jennifer N. Brudno et al. · Journal of Clinical Oncology Open access 29 May 2018 800
2 Quantitative comparison of DNA methylation assays for biomarker development and clinical applications Christoph Bock et al. · Nature Biotechnology Open access 27 Jun 2016 354
3 Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer Xu Chen et al. · Journal of Clinical Investigation Open access 20 Aug 2020 269
4 Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting LV Kalman et al. · Clinical Pharmacology & Therapeutics Open access 20 Oct 2015 182
5 Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR Sang Yun Ha, So‐Jung Choi, Jong Ho Cho et al. · Oncotarget Open access 28 Feb 2015 163
All 49 most cited papers, with filters and sorting

Which keywords describe research at Asana Biosciences (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Immune Response, Medicinal Chemistry, Glycosylation, Cancer Therapy, Oncogenic Mutations, BRAF gene and MAP Kinase.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Immune Response3▲ 18×2 topics
  2. Targeted Therapy3▲ 51×4 topics
  3. Medicinal Chemistry3▲ 28×3 topics
  4. Glycosylation2▲ 38×3 topics
  5. Cancer Therapy2▲ 13×2 topics
  6. Oncogenic Mutations2▲ 179×2 topics
  7. BRAF gene2▲ 435×1 topic
  8. MAP Kinase2▲ 435×1 topic
  9. Cell-Free DNA2▲ 80×2 topics
  10. Chemotherapy2▲ 10×7 topics
  11. Fc Receptors2▲ 70×1 topic
  12. Therapeutic Antibodies2▲ 54×1 topic
  13. Inflammation2▲ 2.8×4 topics
  14. Pharmacokinetics2▲ 24×2 topics
  15. Cancer2▲ 4.3×5 topics
  16. Breast Cancer2▲ 21×3 topics
  17. Anticancer Agents1▲ 21×1 topic
  18. Heterocyclic Compounds1▲ 34×1 topic
  19. Cancer Genomics1▲ 92×1 topic
  20. Monoclonal Antibody1▲ 70×2 topics
  21. Mutational Signatures1▲ 92×1 topic
  22. HER21▲ 156×1 topic
  23. Molecular Docking1▲ 33×1 topic
  24. Trastuzumab1▲ 110×1 topic
  25. Virtual Screening1▲ 67×1 topic
  26. PET Imaging1▲ 19×2 topics

Which research topics does Asana Biosciences (United States) publish most on?

By volume in 2022-now: Pharmacogenetics and Drug Metabolism, Advanced Proteomics Techniques and Applications, Cancer Genomics and Diagnostics and Metabolomics and Mass Spectrometry Studies.

  1. 1 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  2. 2 Advanced Proteomics Techniques and Applications Spectroscopy 0 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 0 works
  4. 4 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
  5. 5 Genomics and Rare Diseases Genetics 0 works
  6. 6 Mass Spectrometry Techniques and Applications Spectroscopy 0 works
  7. 7 BRCA gene mutations in cancer Genetics 0 works
  8. 8 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  9. 9 Cancer therapeutics and mechanisms Molecular Biology 0 works
  10. 10 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.1%not open57.9%

World: 40% of research is openly available.

with international co-authors33.3%domestic only66.7%

World: 18% is written across borders.

How has Asana Biosciences (United States)'s research output changed?

Output in 2022-2025 was 75% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Asana Biosciences (United States) as a percentage of every work published that year, 0.000015% in 2024.

still counting0.000050%0.00010%0.00015%Asana Biosciences (United States)0.000022% in 202520102020

Fractional works of Asana Biosciences (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lawrenceville

All research institutions in Lawrenceville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Asana Biosciences (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.